Stock Comparison

BIIB vs LLY

Biogen Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.

BIIB

Biogen Inc

Healthcare

LLY

Eli Lilly and Company

Healthcare

Valuation

Market Cap

$31.89B

$1.08T

P/E (TTM)

23.3

42.9

Forward P/E

14.5

31.1

Price/Sales

3.2

14.9

Price/Book

1.6

32.2

EV/EBITDA

11.9

28.8

Dividend Yield

—

0.55%

Profitability

Net Margin

13.80%

35.00%

Operating Margin

22.90%

49.40%

Return on Equity

7.70%

107.50%

Return on Assets

5.95%

20.70%

Growth (YoY)

Revenue Growth

1.90%

55.50%

Earnings Growth

31.10%

169.90%

Price & Risk

Beta

0.2

0.5

52-Week High

$218.06

$1,215.76

52-Week Low

$121.05

$619.40

Analyst Target

$220.25

$1,222.62

Compare BIIB and LLY your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.